1. Aripiprazole-related risk of increased urge to gamble

   News item 06 January 2024 Pages: 1 - 1

2. Compounded semaglutide-like products: TGA Australia warns of safety risks

   News item 06 January 2024 Pages: 2 - 2

3. Fat-dissolving injection-related adverse events

   News item 06 January 2024 Pages: 3 - 3

4. GLP-1 receptor agonists: warning on proper use

   News item 06 January 2024 Pages: 4 - 4

5. Monitoring risk factors for paracetamol hepatotoxicity

   News item 06 January 2024 Pages: 5 - 5

6. Montelukast: new boxed warning on neuropsychiatric AEs

   News item 06 January 2024 Pages: 6 - 6

7. Oral anticoagulants, risk of acute kidney injury

   News item 06 January 2024 Pages: 7 - 7

8. Sudden deafness reported after COVID-19 vaccination

   News item 06 January 2024 Pages: 8 - 8

9. Unauthorised injectable drugs from Canlab may pose health risks

   News item 06 January 2024 Pages: 9 - 9

10. Vitamin B12 products: risk of sensitivity reactions in patients with cobalt allergy

    News item 06 January 2024 Pages: 10 - 10

11. Statins reduce risk of hormone therapy-related VTE

    Clinical study 06 January 2024 Pages: 11 - 11

12. Thiazide-associated hyponatraemia increases risk of MACE in elderly

    Clinical study 06 January 2024 Pages: 12 - 12

13. Other adverse reaction research

    News item 06 January 2024 Pages: 13 - 13

14. Abemaciclib

    Case report 06 January 2024 Pages: 14 - 14

15. Adalimumab/betamethasone

    Case report 06 January 2024 Pages: 15 - 15

16. Adalimumab/Duloxetine/Ustekinumab

    Case report 06 January 2024 Pages: 16 - 16

17. Adenosine/Amiodarone/Furosemide

    Case report 06 January 2024 Pages: 17 - 17

18. Alendronic-acid/denosumab/methotrexate

    Case report 06 January 2024 Pages: 18 - 18

19. Allopurinol

    Case report 06 January 2024 Pages: 19 - 19

20. Alprazolam/Bupropion

    Case report 06 January 2024 Pages: 20 - 20

21. Alprazolam/fluvoxamine/quetiapine

    Case report 06 January 2024 Pages: 21 - 21

22. Alteplase

    Case report 06 January 2024 Pages: 22 - 22

23. Amantadine/Prednisolone-acetate/Sodium-chloride

    Case report 06 January 2024 Pages: 23 - 23

24. Amorolfine/terbinafine

    Case report 06 January 2024 Pages: 24 - 24

25. Amoxicillin/clavulanic-acid

    Case report 06 January 2024 Pages: 25 - 25

26. Amphotericin-B-liposomal/deoxycholic-acid/pentamidine

    Case report 06 January 2024 Pages: 26 - 26

27. Anabolic-steroids/clenbuterol/dinitrophenol misuse

    Case report 06 January 2024 Pages: 27 - 27

28. Anti-inflammatories/Bimekizumab/Elasomeran

    Case report 06 January 2024 Pages: 28 - 28

29. Antiarrhythmics

    Case report 06 January 2024 Pages: 29 - 29

30. Antiasthmatics/Atracurium-besilate/Heparin

    Case report 06 January 2024 Pages: 30 - 30

31. Antineoplastics

    Case report 06 January 2024 Pages: 31 - 31

32. Antineoplastics

    Case report 06 January 2024 Pages: 32 - 32

33. Antineoplastics/pegfilgrastim

    Case report 06 January 2024 Pages: 33 - 33

34. Aspirin/prednisone

    Case report 06 January 2024 Pages: 34 - 34

35. Atezolizumab

    Case report 06 January 2024 Pages: 35 - 35

36. Atezolizumab/bevacizumab

    Case report 06 January 2024 Pages: 36 - 36

37. Atezolizumab/bevacizumab

    Case report 06 January 2024 Pages: 37 - 37

38. Avatrombopag

    Case report 06 January 2024 Pages: 38 - 38

39. Axicabtagene-ciloleucel/tisagenlecleucel

    Case report 06 January 2024 Pages: 39 - 39

40. Axitinib/pembrolizumab

    Case report 06 January 2024 Pages: 40 - 40

41. Axitinib/Pembrolizumab

    Case report 06 January 2024 Pages: 41 - 41

42. Azacitidine

    Case report 06 January 2024 Pages: 42 - 42

43. Azacitidine

    Case report 06 January 2024 Pages: 43 - 43

44. Azacitidine/Venetoclax

    Case report 06 January 2024 Pages: 44 - 44

45. Azathioprine/infliximab

    Case report 06 January 2024 Pages: 45 - 45

46. AZD-1222

    Case report 06 January 2024 Pages: 46 - 46

47. AZD-1222

    Case report 06 January 2024 Pages: 47 - 47

48. AZD-1222/Elasomeran

    Case report 06 January 2024 Pages: 48 - 48

49. AZD-1222/elasomeran/tozinameran

    Case report 06 January 2024 Pages: 49 - 49

50. AZD-1222/tozinameran

    Case report 06 January 2024 Pages: 50 - 50